GSK3B and malignant colon neoplasm: Treatment with LiCl or transfection with DNGSK3β rescued effectively the intracellular β-catenin/TCF transcriptional activity inhibited by Z86, indicating that Z86 inhibited Wnt signaling through activation of GSK3β in colon cancer cells (Figure 4b).